Carisma Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	2.78	17.91	77.61	24.19	28.55	51.79
Short-Term Investments	-	0.93	0.89	27.8	-	-
Cash & Short-Term Investments	2.78	18.83	78.5	52	28.55	51.79
Cash Growth	-90.13%	-76.01%	50.97%	82.12%	-44.87%	-
Receivables	1.64	2.86	-	-	-	-
Prepaid Expenses	1.41	0.34	0.4	2.6	1.24	1.28
Other Current Assets	0.05	1.79	1.57	-	-	-
Total Current Assets	5.87	23.83	80.47	54.59	29.79	53.07
Property, Plant & Equipment	0.68	6.43	8.94	13.45	5.66	5.19
Long-Term Deferred Charges	-	0.21	0.15	4.11	-	-
Other Long-Term Assets	-	-	-	-	-	0.21
Total Assets	6.55	30.46	89.55	72.15	35.45	58.46
Accounts Payable	5.57	2.08	3.93	1.73	2.32	3.29
Accrued Expenses	1.09	7.45	7.66	10.36	4.47	1.57
Current Portion of Leases	0.15	1.74	1.94	4.6	0.9	0.81
Current Unearned Revenue	-	3.73	1.41	2.46	-	-
Other Current Liabilities	-	1.06	0.97	0.52	-	-
Total Current Liabilities	6.81	16.06	15.91	19.67	7.69	5.68
Long-Term Debt	-	-	-	33.72	-	-
Long-Term Leases	0.61	0.74	1.19	1.85	1.73	2.63
Long-Term Unearned Revenue	-	41.25	45	45	-	-
Other Long-Term Liabilities	-	0.32	0.93	6.78	-	-
Total Liabilities	7.42	58.37	63.02	107.02	9.43	8.31
Common Stock	0.04	0.04	0.04	0	-	-
Additional Paid-In Capital	278.99	277.63	271.59	1.2	0.82	0.34
Retained Earnings	-279.9	-305.58	-245.1	-158.22	-97	-56.21
Comprehensive Income & Other	-	-	-	-0.04	-	-
Total Common Equity	-0.87	-27.91	26.53	-157.07	-96.18	-55.87
Minority Interest	-	-	-	14.4	14.4	14.4
Shareholders' Equity	-0.87	-27.91	26.53	-34.86	26.02	50.15
Total Liabilities & Equity	6.55	30.46	89.55	72.15	35.45	58.46
Total Debt	0.76	2.48	3.12	40.16	2.63	3.45
Net Cash (Debt)	2.02	16.35	75.37	11.83	25.92	48.34
Net Cash Growth	-91.88%	-78.30%	537.03%	-54.35%	-46.38%	-
Net Cash Per Share	0.05	0.39	2.25	5.56	23.91	45.46
Filing Date Shares Outstanding	41.85	41.79	41.54	1.17	11.09	1.06
Total Common Shares Outstanding	41.79	41.75	40.61	1.17	1.08	1.06
Working Capital	-0.94	7.77	64.56	34.92	22.1	47.39
Book Value Per Share	-0.02	-0.67	0.65	-134.52	-88.72	-52.55
Tangible Book Value	-0.87	-27.91	26.53	-157.07	-96.18	-55.87
Tangible Book Value Per Share	-0.02	-0.67	0.65	-134.52	-88.72	-52.55
Machinery	-	4.82	5.36	7.63	3.96	2.09
Construction In Progress	-	-	0.01	0.01	0.01	-
Leasehold Improvements	-	0.34	0.34	0.34	0.32	0.32

Source: S&P Global Market Intelligence. Standard template. Financial Sources.